Anti-LRIG2 antibodies are used in the immunodetection of the protein leucine rich repeats and immunoglobulin like domains 2. In humans, the canonical protein has a reported length of 1065 amino acid residues and a mass of 119 kDa. Its subcellular localization is in the cell membrane and cytoplasm. It is notably expressed in all tissues analyzed. Post-translational modifications have been described, including glycosylation. The LRIG2 gene has been associated with the disease, Urofacial syndrome. Synonyms for this target antigen include LIG-2 and LIG2. LRIG2 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish and chicken species. A number of LRIG2 antibodies have been mentioned in research publications and have associated citations. Immunohistochemistry is a widely used application for these antibodies. ELISA, Western Blot, and Immunofluorescence are also common applications.